Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
Details for Australian Patent Application No. 2010229711 (hide)
International Classifications
Event Publications
27 October 2011 PCT application entered the National Phase
PCT publication WO2010/111631 Priority application(s): WO2010/111631
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2010229713-Antibody composition with altered Fab sialylation
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser